Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 19 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 11472888

    Reelin antibodies for treatment of atherosclerosis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  2. US 11471449

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  3. US 11471509

    Compositions and methods relating to myomaker-induced muscle cell fusion

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  4. US 11472813

    OX2R compounds

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  5. US 11464843

    Use of the salmonella SPP type III secretion proteins as a protective vaccination

    The Board of Regents for Oklahoma State University · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  6. US 11466017

    Heterocyclic inhibitors of PTPN11

    The Board of Regents of the University of Texas System · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  7. US 11459617

    Targeted measure of transcriptional activity related to hormone receptors

    The Board of Regents of the University of Texas System · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  8. US 11458212

    Molecular imaging of cancer cells in vivo

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  9. US 11458203

    Pharmaceutical compositions comprising caffeic acid chelates

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  10. US 11459564

    Modulation of frataxin expression

    The Board of Regents of the University of Texas System · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  11. US 11458136

    Antiviral prodrugs and formulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  12. US 11452775

    Detection of arginine methylation of EGFR for prediction of resistance to therapy

    The Board of Regents of the University of Texas System · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  13. US 11447452

    Agonists of peroxisome proliferator-activated receptor alpha and methods of use

    The Board of Regents of the University of Oklahoma · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  14. US 11447753

    Non-neuroinvasive viruses and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  15. US 11446353

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  16. US 11446365

    Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  17. US 11446302

    Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  18. US 11447830

    Gene signatures to predict drug response in cancer

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  19. US 11440885

    Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  20. US 11439650

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  21. US 11432547

    Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  22. US 11434233

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  23. US 11426464

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  24. US 11426448

    Methods for treatment of erectile dysfunction with sonic hedgehog compounds

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted